Drug intelligence / Profile preview

juniperus oxycedrus allergen extract + cupressus arizonica allergen extract

Development stage
Preclinical
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal
01

Overview

This is a biologic allergen extract combining pollen from Juniperus oxycedrus (prickly juniper) and Cupressus arizonica (Arizona cypress), two plants in the Cupressaceae family. It is being developed as an in-house reference preparation for standardizing allergy diagnostic tests, specifically skin prick tests. [3-1, 3-2] The product is intended for the diagnosis of inhalant allergies such as rhinitis, rhinoconjunctivitis, and/or asthma in patients with a clinical history of sensitivity to these pollens. [3-13, 4-23] It works by targeting the immune system, specifically triggering an IgE-mediated response upon intradermal administration in sensitized individuals, allowing for the confirmation of an allergy. Due to significant cross-reactivity within the Cupressaceae family, individuals allergic to one species often react to others.

02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on juniperus oxycedrus allergen extract + cupressus arizonica allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on juniperus oxycedrus allergen extract + cupressus arizonica allergen extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call